about
Identification of druggable cancer driver genes amplified across TCGA datasetsDefining the sister rat mammary tumor cell lines HH-16 cl.2/1 and HH-16.cl.4 as an in vitro cell model for Erbb2Tumour microvesicles contain retrotransposon elements and amplified oncogene sequencesSOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomasMechanisms of gene duplication and amplificationThe consequences of nursing stress and need for integrated solutionsUnbalanced replication as a major source of genetic instability in cancer cellsGLO1-A novel amplified gene in human cancerPrevention of DNA re-replication in eukaryotic cellsMechanisms to control rereplication and implications for cancer.Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implicationDifferent Facets of Copy Number Changes: Permanent, Transient, and AdaptiveThe diagnostic value of 11q13 amplification and protein expression in the detection of nodal metastasis from oral squamous cell carcinoma: a systematic review and meta-analysisHER2 in situ hybridization in breast cancer: clinical implications of polysomy 17 and genetic heterogeneityRtt109 prevents hyper-amplification of ribosomal RNA genes through histone modification in budding yeast.A mechanism of gene amplification driven by small DNA fragments.Are Estrogen Receptor Genomic Aberrations Predictive of Hormone Therapy Response in Breast Cancer?Cellular and molecular consequences of defective Fanconi anemia proteins in replication-coupled DNA repair: mechanistic insightsCharacterization of Abcc4 gene amplification in stepwise-selected mouse J774 macrophages resistant to the topoisomerase II inhibitor ciprofloxacinFenton reaction induced cancer in wild type rats recapitulates genomic alterations observed in human cancerGemcitabine eliminates double minute chromosomes from human ovarian cancer cellsInferring tumor progression from genomic heterogeneityThe landscape of somatic copy-number alteration across human cancers.Role of autophagy in cancerAcinetobacter baylyi ADP1: transforming the choice of model organism.Breakpoint profiling of 64 cancer genomes reveals numerous complex rearrangements spawned by homology-independent mechanisms.Overexpression limits of fission yeast cell-cycle regulators in vivo and in silico.High resolution genome-wide analysis of chromosomal alterations in Burkitt's lymphomaGene dosage, expression, and ontology analysis identifies driver genes in the carcinogenesis and chemoradioresistance of cervical cancer.GeneCount: genome-wide calculation of absolute tumor DNA copy numbers from array comparative genomic hybridization data.Characterization of novel and complex genomic aberrations in glioblastoma using a 32K BAC array.Integrative genomic analyses identify BRF2 as a novel lineage-specific oncogene in lung squamous cell carcinomaGene amplification of the histone methyltransferase SETDB1 contributes to human lung tumorigenesis.The Ca2+-activated Cl- channel ANO1/TMEM16A regulates primary ciliogenesisProteomic changes resulting from gene copy number variations in cancer cellsIdentification of candidate epigenetic biomarkers for ovarian cancer detection.A common copy-number breakpoint of ERBB2 amplification in breast cancer colocalizes with a complex block of segmental duplications.Relationships linking amplification level to gene over-expression in gliomasAssessing metabolic stress and autophagy status in epithelial tumors.Role of autophagy in breast cancer.
P2860
Q21090621-9F3BECB7-4571-43EE-B8D6-161ABE954CA2Q21134904-11F9CAD6-14B6-48D7-8D2C-A2F7C440619DQ21147057-12EC41E3-1DA3-4538-9D9A-132184ADA970Q21562575-A7444131-58BC-42C6-A9D0-99E6EB2B2EE5Q22065788-C83C174C-6C0C-4634-AE94-9F86A591C142Q23919968-7E028F90-1684-4F0D-92DB-52F6656D9719Q24621737-C7F0E882-ECD7-438C-95B3-879F2AFA33C0Q24631249-3F05F081-D1CC-4982-9BFA-DDA974011584Q24632601-CB7BCC30-6C7F-4A88-9FB6-A91366F4C26CQ24669595-42E47B78-662C-46A6-909F-E6D7FF807782Q26745972-57D51005-1773-4826-8268-CFE3A751704AQ26769649-BC18205B-BAC1-4BA5-B3D1-128A78E9B3D2Q26996809-DD25E8E4-1AA1-4B7E-BA21-DA85E337619BQ27006811-0D7FBBFF-AA50-4830-AC73-79FE3B053FE3Q27929531-15D45142-CF89-4F85-928A-CDEF909A93FDQ27930879-F0DDD4DB-677F-473F-BBAA-ED3BEF03A5E9Q28074060-16149A74-5261-4EE6-88DB-59B0BCA682DCQ28252640-8A25DF5B-5149-4B6B-84E6-8303DB3B02ACQ28478263-92F15439-0161-4E07-87CF-2A321B74006AQ28483012-58B37D1C-9742-4805-AC25-D346E6CADB46Q28535582-A2AB3076-6F80-4CD9-9038-0A645A71EACDQ28749457-190A1047-E051-4FAB-B239-CFEE3A1C30B4Q29547648-CB927B87-D39D-454B-BCCE-DC6BB166D5BAQ29620348-D07360BA-D45E-42E9-A40D-C300472E6646Q30408700-859857D1-EEC2-4ABC-A1B0-E9D2E544C56AQ30416550-8FAAC66D-BFC5-4E1C-B388-0D55B309C29AQ30542457-A1A7170A-BC8C-4354-B558-8E20671AE15CQ30873773-7C39C9CA-E976-44B7-AFEF-171000F06BB9Q30884181-DD139D36-F6B5-42C9-A0A6-449A22346CE3Q31156446-A968B53A-040B-4841-A551-63DD0E4A96CFQ33574552-CFADE449-DC4B-4606-B9D5-B75F297B778BQ33644421-E55C159A-CBEE-4487-956F-54E1EEB937C5Q33652528-3B3C0CAA-D14F-4166-ABF5-70B54B80C02FQ33685673-C5CD452A-6C86-48FF-9647-5D35CE902C8EQ33686899-F58012CA-11C2-44E0-898A-1EB57B2BC0E1Q33690825-11AE3DBE-305A-4C4D-A89A-AA8CA0717583Q33739397-C68C2A9A-2E74-4ECD-A710-E4F833622A40Q33775591-EBD692D6-3ACC-4689-9088-806C591F8941Q33801671-043260AE-E3FC-4BB4-8363-A3A18228AC4DQ33808483-AF50EDED-93DF-4CB9-AA4C-B079841B97DD
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Gene amplification in cancer.
@ast
Gene amplification in cancer.
@en
Gene amplification in cancer.
@nl
type
label
Gene amplification in cancer.
@ast
Gene amplification in cancer.
@en
Gene amplification in cancer.
@nl
prefLabel
Gene amplification in cancer.
@ast
Gene amplification in cancer.
@en
Gene amplification in cancer.
@nl
P1433
P1476
Gene amplification in cancer.
@en
P2093
Donna G Albertson
P304
P356
10.1016/J.TIG.2006.06.007
P577
2006-06-19T00:00:00Z